Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard E Champlin

Showing results (1-10 of 500) with videos related to

Pageof 50
Sort By:
Blood|December 7, 2013
Busulfan or TBI: answer to an age-old questionRichard E Champlin
Blood|December 7, 2007
Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challengesPaolo Anderlini, Richard E Champlin
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 2, 2006
Reduced intensity conditioning for allogeneic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: where do we stand?Paolo Anderlini, Richard E Champlin
Current Opinion in Oncology|February 28, 2008
Peripheral blood progenitor cell or bone marrow transplantation: controversy remainsEbru Koca, Richard E Champlin
Clinical Advances in Hematology & Oncology : H&O|November 1, 2005
Current evaluation of imatinib and allogeneic transplant in the treatment of chronic myeloid leukemiaRichard E Champlin, Hagop Kantarjian
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2016
Epstein-Barr Virus and B Cells in the Pathogenesis of Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem-Cell TransplantationKatayoun Rezvani, Richard E Champlin
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 25, 2011
Outcomes of patients treated and one human leukocyte antigen-mismatched related compared with matched unrelated donorsStefan O Ciurea, Richard E Champlin
Cancer Journal (Sudbury, Mass.)|September 26, 2012
Nonmyeloablative allogeneic stem cell transplantation for non-hodgkin lymphomaIssa F Khouri, Richard E Champlin
Transplantation and Cellular Therapy|November 6, 2024
Mass Radiation Exposure: Lessons of Chernobyl, Transplant Center Preparations and the Radiation Injury Treatment NetworkRichard E Champlin, Nelson J Chao
Blood|January 22, 2011
Can Treg therapy prevent GVHD?Krishna V Komanduri, Richard E Champlin
Pageof 50

Showing results (1-10 of 500) with videos related to

Sort By:
Pageof 50
Blood|December 7, 2013
Busulfan or TBI: answer to an age-old questionRichard E Champlin
Blood|December 7, 2007
Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challengesPaolo Anderlini, Richard E Champlin
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 2, 2006
Reduced intensity conditioning for allogeneic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: where do we stand?Paolo Anderlini, Richard E Champlin
Current Opinion in Oncology|February 28, 2008
Peripheral blood progenitor cell or bone marrow transplantation: controversy remainsEbru Koca, Richard E Champlin
Clinical Advances in Hematology & Oncology : H&O|November 1, 2005
Current evaluation of imatinib and allogeneic transplant in the treatment of chronic myeloid leukemiaRichard E Champlin, Hagop Kantarjian
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2016
Epstein-Barr Virus and B Cells in the Pathogenesis of Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem-Cell TransplantationKatayoun Rezvani, Richard E Champlin
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 25, 2011
Outcomes of patients treated and one human leukocyte antigen-mismatched related compared with matched unrelated donorsStefan O Ciurea, Richard E Champlin
Cancer Journal (Sudbury, Mass.)|September 26, 2012
Nonmyeloablative allogeneic stem cell transplantation for non-hodgkin lymphomaIssa F Khouri, Richard E Champlin
Transplantation and Cellular Therapy|November 6, 2024
Mass Radiation Exposure: Lessons of Chernobyl, Transplant Center Preparations and the Radiation Injury Treatment NetworkRichard E Champlin, Nelson J Chao
Blood|January 22, 2011
Can Treg therapy prevent GVHD?Krishna V Komanduri, Richard E Champlin
Pageof 50